LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Wageningen University

Status and phase: Completed; Phase 2

Conditions: Hypertension

Treatments: Behavioral: dairy peptides

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00167869

METC-WU 04/04

Details and patient eligibility

About

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

Sex: All

Ages: 35 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• systolic blood pressure >= 140 mmHg
• BMI between 18 and 32 kg/m2
• apparently healthy

Exclusion criteria

• antihypertensive medication
• medically prescribed or slimming diet
• lactating, pregnant
• irregular pulse

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind